Investor · 1 deal
Every published round Medical Device Partnering Program took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Peak Medical | Accelerator | 29 Apr 2022 | - | Lead | Wholesale Investor (Fri 29 Apr 2022), Wholesale Investor (Fri 18 Jun 2021), Wholesale Investor (Mon 14 Dec 2020) |
Companies Medical Device Partnering Program has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Peak Medical | 29 Apr 2022, Accelerator | 1 | 1 |
Fund closes reported for Medical Device Partnering Program, as distinct from the investments it has made.
Companies Medical Device Partnering Program has backed that another company then bought. An exit for the holding, not a deal Medical Device Partnering Program did.
| Name | Role | Sources |
|---|---|---|
| Karen Reynolds | Director | Wholesale Investor |
Stories naming Medical Device Partnering Program. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Peak Medical's acceptance into the Medical Device Partnering Program is announced, alongside MTPConnect launching a government-funded medtech commercialisation program with partners including Flinders University and Cicada Innovations.
Cincera Therapeutics has received a million-dollar Biomedical Translation Bridge grant to advance its Des-1 inhibitor drug for obesity-related metabolic diseases. The Monash and UniSA spin-out previously secured venture funding from the Medical Research Commercialisation Fund.